de Zeeuw Dick
Department of Clinical Pharmacology, University of Groningen, Ant Deusingglaan 1, 9713 AV Groningen, The Netherlands.
Hosp Med. 2003 Feb;64(2):96-100.
Many patients with non-diabetic and diabetic renal disease undergo chronic renal function loss leading to dialysis or renal transplantation. The US National Kidney Foundation guidelines recommend that angiotensin-converting enzyme inhibitors and angiotensin type receptor antagonists are first choice therapy for these patients.
许多非糖尿病和糖尿病肾病患者会出现慢性肾功能丧失，最终导致透析或肾移植。美国国家肾脏基金会指南建议，血管紧张素转换酶抑制剂和血管紧张素受体拮抗剂是这些患者的首选治疗药物。
